Live Price
Live Volume
Chart Volume 0
Volume 0
5 secNektar Therapeutics Market Segments
Overnight
+2.31(+3.85%)
| Open | $60.00 |
|---|---|
| Close | $62.31 |
| Low | $59.99 |
| Low Change | -0.01 (-0.02%) |
| High | $62.31 |
| High Change | +2.31 (+3.85%) |
| Range | $2.32 |
| Volume | 925 |
| Dollar Volume | $57.64K |
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
+0.62(+1.04%)
| Open | $59.38 |
|---|---|
| Close | $60.00 |
| Low | $57.20 |
| Low Change | -2.18 (-3.67%) |
| High | $60.95 |
| High Change | +1.57 (+2.64%) |
| Range | $3.75 |
| Volume | 121.094K |
| Dollar Volume | $7.27M |
Regular Trading Hours Yesterday
+1.29(+2.22%)
| Open | $58.03 |
|---|---|
| Close | $59.32 |
| Low | $56.21 |
| Low Change | -1.82 (-3.14%) |
| High | $61.79 |
| High Change | +3.76 (+6.48%) |
| Range | $5.58 |
| Volume | 1.917M |
| Dollar Volume | $113.72M |
Premarket Yesterday
-0.20(-0.34%)
| Open | $58.31 |
|---|---|
| Close | $58.11 |
| Low | $57.16 |
| Low Change | -1.16 (-1.98%) |
| High | $59.11 |
| High Change | +0.80 (+1.37%) |
| Range | $1.96 |
| Volume | 11.326K |
| Dollar Volume | $658.15K |
Nektar Therapeutics News
Nektar Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Nektar Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $62.37 |
|---|---|
| 10 Day Moving Average (SMA10) | $65.25 |
| 20 Day Moving Average (SMA20) | $69.27 |
| 50 Day Moving Average (SMA50) | $71.07 |
| 100 Day Moving Average (SMA100) | $69.45 |
| 200 Day Moving Average (SMA200) | $65.43 |
Nektar Therapeutics Statistics
| Average Volume (30 Days) | 887.92K |
|---|---|
| P/E Ratio (Current) | -12.53 |
| EPS (Current) | -$4.60 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$234.03M |
| Cash Ratio | 0.55 |
| Current Ratio | 10.42 |
| Quick Ratio | 10.42 |
| Debt to Equity | 0.00 |
| Enterprise Value | $1.93B |
| EV to EBITDA | -14.85 |
| EV to Sales | 35.34 |
| Price to Book | 2.18 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 36.06 |
| Return on Assets | -0.14% |
| Return on Equity | -0.17% |
Nektar Therapeutics Stock Splits
There has been 1 stock split for Nektar Therapeutics (NKTR). The reverse stock split occured on June 9, 2025 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 9, 2025 | Reverse | 15:1 |
Nektar Therapeutics Dividends
There have been no dividends for Nektar Therapeutics (NKTR).